Nasdaq · CIK 0002079109
VRXA Veraxa Biotech AG - Post de-SPAC
Insider trading from SEC Form 4. Last filing not yet seen. Close $1.26 on Oct 9, 2026, +17% from the 52-week low and -95% from the high.
Veraxa Biotech AG - Post de-SPAC (VRXA) has no SEC Form 4 filing on file yet. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
VRXA closed at $1.26 on Oct 9, 2026, 17% above its 52-week low and 95% below its 52-week high.
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Veraxa Biotech AG - Post de-SPAC, scored.
Transactions
Every row filed, 0 in all.
Insiders
Everyone who has filed a Form 4 here.
Questions about VRXA
Answered from the filings on this page, as of the latest one.
Are insiders buying VRXA?
No. In the last 90 days no insider at Veraxa Biotech AG - Post de-SPAC bought or sold shares on the open market according to SEC Form 4 filings. No Form 4 has been filed yet.
Who was the last insider to trade VRXA on the open market?
No open-market trade has been scored at Veraxa Biotech AG - Post de-SPAC. No Form 4 is on file yet.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.